- Home
- GILD vs DELL Comparison
GILD vs DELL Comparison
Compare GILD & DELL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GILD | DELL |
|---|---|---|
| Founded | 1987 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Manufacturing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.3B | 191.7B |
| IPO Year | 2003 | 2013 |
Fundamental Metrics
Financial Performance| Metric | GILD | DELL |
|---|---|---|
| Price | $127.91 | $394.88 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 17 |
| Target Price | $148.39 | ★ $181.63 |
| AVG Volume (30 Days) | 7.8M | ★ 10.0M |
| Earning Date | 05-07-2026 | 05-28-2026 |
| Dividend Yield | ★ 2.55% | 1.23% |
| EPS Growth | ★ 1684.21 | 36.05 |
| EPS | 1.61 | ★ 5.24 |
| Revenue | $24,689,000,000.00 | ★ $113,538,000,000.00 |
| Revenue This Year | $4.68 | $26.19 |
| Revenue Next Year | $6.04 | $8.60 |
| P/E Ratio | ★ $76.82 | $78.02 |
| Revenue Growth | 9.98 | ★ 18.80 |
| 52 Week Low | $107.75 | $110.22 |
| 52 Week High | $157.29 | $469.47 |
Technical Indicators
Market Signals| Indicator | GILD | DELL |
|---|---|---|
| Relative Strength Index (RSI) | 44.56 | 55.53 |
| Support Level | $116.55 | $122.88 |
| Resistance Level | $126.81 | $469.47 |
| Average True Range (ATR) | 3.53 | 28.59 |
| MACD | 0.17 | -6.80 |
| Stochastic Oscillator | 45.06 | 41.32 |
Price Performance
Historical ComparisonAbout GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
About DELL Dell Technologies Inc.
Dell Technologies is a broad information technology vendor, primarily supplying hardware to enterprises. It focuses on premium and commercial personal computers, as well as enterprise on-premises data center hardware. It holds top-three shares in its core markets of personal computers, peripheral displays, mainstream servers, and external storage. Dell has a robust ecosystem of component and assembly partners and also relies heavily on channel partners to fulfill its sales.